Effectiveness and Safety of Cellbooster Glow in Healthy Subjects - NCT07929870
The current post-market clinical investigation is designed to evaluate the efficacy and safety of Cellbooster Glow (CBG). For this purpose, healthy participants with signs of skin aging in the face will receive a 3-session treatment and will be followed-up over 70 days after the initial injection session. Several objective measurements of skin quality will be performed with different instruments allowing to assess skin wrinkles, elasticity, dryness, pigmentation, roughness, overall inflammation and microcirculation. Subjective clinical improvement will be evaluated, as well as participant and investigator satisfactions. The safety of the injections will be assessed by collecting the Injection Site Reactions (ISRs) and Adverse Events (AEs).
- Company
- Suisselle
- Keywords
- Wrinkle Appearance, Skin Hydration in Healthy Volunteers, Skin Pigmentation, Skin Laxity, Dark Eye Circles (Periorbital Hyperpigmentation), wrinkle, aesthetic medicine, Cellbooster Glow, skin booster, Intradermal injection, papula, medical device, hyaluronic acid, vitamins, amino-acids, dark circles, pigmentation, skin microcirculation, skin elasticity, patient satisfaction, Corneometer, skin roughness, Injection Site Reactions, mesotherapy, aesthetic procedure, injectable, GAIS